TABLE 3.
Demographics, symptoms, and comorbidities of 140 patients positive for SARS-CoV-2 by RT-PCR and tested for IgG in this study
| Parameter | Value (%) |
|---|---|
| Demographics | |
| No. of female | 65 (46.4) |
| No. of males | 75 (53.6) |
| No. of nursing home residents | 37 (26.4) |
| Age (avg) in yrs | 68.0 |
| Symptoms | |
| No. with fever | 83 (59.3) |
| No. with cough | 64 (45.7) |
| No. with headache | 12 (8.6) |
| No. with sore throat | 10 (7.1) |
| No. with shortness of breath | 78 (55.7) |
| No. with altered mental status | 45 (32.1) |
| No. with malaise | 36 (25.7) |
| No. with diarrhea/vomiting | 42 (30.0) |
| Course of disease/complications | |
| No. of days of hospitalization (avg) | 13.8 |
| No. with ICU admission | 66 (47.1) |
| No. with low oxygen saturation | 75 (53.6) |
| No. with ventilation | 47 (33.6) |
| No. with septic shock/vasopressor | 28 (20.0) |
| No. with bacterial pneumonia | 28 (20.0) |
| No. deceased | 20 (14.3) |
| Comorbidities | |
| No. with asthma | 15 (10.7) |
| No. with COPD | 13 (9.3) |
| No. with diabetes | 56 (40.0) |
| No. with hypertension | 100 (71.4) |
| No. with obstructive sleep apnea | 24 (17.1) |
| No. with coronary artery disease | 19 (13.6) |
| No. with cerebrovascular disease | 25 (17.9) |
| No. with immunodeficiency/immunosuppression | 11 (7.9) |
| No. with history of smoking | 77 (55.0) |
| Total | 140 (100) |